Invention Grant
- Patent Title: Fumarate salts of a histamine H3 receptor antagonist
- Patent Title (中): 组胺H3受体拮抗剂的富马酸盐
-
Application No.: US13314772Application Date: 2011-12-08
-
Publication No.: US08664245B2Publication Date: 2014-03-04
- Inventor: Beverly C. Langevin , Robert Allan Farr , Dinubhai H. Shah , Daniel Sherer
- Applicant: Beverly C. Langevin , Robert Allan Farr , Dinubhai H. Shah , Daniel Sherer
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agent Kelly L. Bender
- Priority: FR0959110 20091217
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/47 ; C07D217/00
Abstract:
The disclosure relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, to pharmaceutical compositions thereof, processes for making the same, and methods of use thereof.
Public/Granted literature
- US20120149728A1 NOVEL FUMARATE SALTS OF A HISTAMINE H3 RECEPTOR ANTAGONIST Public/Granted day:2012-06-14
Information query
IPC分类:
